This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Sept. 3, 2013 /PRNewswire/ --
Shareholder rights attorneys at Robbins Arroyo LLP announce that an investor of NuVasive, Inc. (NASDAQ: NUVA) ("NuVasive") has filed a complaint in the U.S. District Court for the Southern District of California. The complaint alleges that the company and certain of its officers violated the Securities Exchange Act of 1934 between
October 22, 2008 and
July 30, 2013 (the "Class Period"). NuVasive designs, develops, and markets minimally disruptive surgical products and procedurally integrated solutions for the spine.
NuVasive Accused of Making False and Misleading Statements
According to the complaint, certain NuVasive officers made false and misleading statements and failed to disclose information regarding the company's operation, and business prospects. Specifically, the complaint alleges that, throughout the Class Period, the company and certain of its officers disseminated false and misleading statements and/or failed to disclose that company failed to maintain an effective compliance program as set forth by the U.S. Department of Health and Human Services ("HHS"). Further, because the company lacked an effective compliance program, NuVasive failed to detect that the company had been violating the False Claims Act by submitting false claims to Medicare and Medicaid. As a result of the foregoing, NuVasive shares traded at artificially inflated prices during the Class Period.
NuVasive Stock Drops on News of HHS Investigation
July 30, 2013, according to the complaint, NuVasive disclosed in a regulatory filing that the company was being investigated by the HHS and had received a subpoena requesting documents for the period
January 2007 through April 2013. The subpoenaed documents relate to the agency's investigation into possible false claims submitted by NuVasive to Medicare and Medicaid. On this news, NuVasive shares dropped 12%, or
$3.28 per share, to close at
July 31, 2013.
If you invested in NuVasive and would like to discuss your
shareholder rights, please contact attorney
Darnell R. Donahue at (800) 350-6003,
email@example.com, or via the
shareholder information form on the firm's website.
Robbins Arroyo LLP is a nationally recognized leader in securities litigation and shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than
$1 billion of value for themselves and the companies in which they have invested. For more information, please go to
Press release link:
Attorney Advertising. Past results do not guarantee a similar outcome.